Skip to the page

Data / Form D filings / ConneX BioMedical, Inc.

ConneX BioMedical, Inc.: Form D filings

ConneX BioMedical, Inc., a health care company in Boulder, CO, filed 2 Form D notices with the SEC between 2021 and 2023. The latest, on March 17, 2023, reports $5.2 million sold of a $5.5 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1434 SPRUCE STREET, SUITE 100, Boulder, CO, 80302
Phone
(847) 373-1405
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1865132

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 17, 2023Amendment$5,500,000$5,155,935$344,0652May 7, 2021sec.gov
Jun 1, 2021New notice$5,000,000$1,000,000$4,000,0001May 7, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Christopher E BanasExecutive Officer, Director
Max B MitchellExecutive Officer, Director

Other health care companies in Colorado that filed recently

Every Form D from the week of Mar 13, 2023 · All recent filings in Colorado · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what ConneX BioMedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.